While much of the focus naturally falls on the scientists, clinicians and researchers leading Actinogen Medical's clinical development program focused on developing a novel therapy to treat Alzheimer's disease by controlling brain cortisol, another challenge is unfolding behind the scenes.

That challenge is financial.

At the centre of it sits Chief Financial Officer; Will Souter.

https://cfomagazine.com.au/the-finance-behind-the-science/